The genetics of multiple sclerosis

Clinical Chemistry and Laboratory Medicine

Volumn 38, Issue 2, 2000, Pages 133-135

  Compston, Alastair ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA;

CONFERENCE PAPER; GENE LOCUS; GENOME; HEREDITY; MULTIPLE SCLEROSIS; PEDIGREE; PRIORITY JOURNAL; RECURRENCE RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0034107695     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2000.020     Document Type: Conference Paper

References (43)

1. Sadovnick AD, Baird PA, Ward RH. Multiple sclerosis; updated risks for relatives. Am J Med Genet 1988; 29:533-41.
2. Robertson NP, Fraser M, Deans J, Clayton D, Compston DAS. Age adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain 1996; 119:449-55.
3. Carton H, Vlietinck R, Debruyne J, et al. Recurrence risks of multiple sclerosis in relatives of patients in Flanders, Belgium. J Neurol Neurosurg Psychiatry 1997; 62:329-33.
4. Sadovnick AD, Armstrong H, Rice GPA, et al. A population-based study of multiple sclerosis in twins: update. Ann Neurol 1993; 33:281-5.
5. French Research Group on Multiple Sclerosis. Multiple sclerosis in 54 twinships: concordance rate is independent of zygosity. Ann Neurol 1992; 32:724-7.
6. Mumford CJ, NW Wood, HF Kellar-Wood, et al. The British Isles survey of multiple sclerosis in twins. Neurology 1994; 44:11-15
7. Sadovnick AD, Ebers GC, Dyment DA, Risch N, the Canadian Collaborative Study Group. Evidence for genetic basis of multiple sclerosis. Lancet 1996; 347:1728-30.
8. Ebers GC, Sadovnick AD, Risch NJ. A genetic basis for familial aggregation in multiple sclerosis. Nature 1995; 377:150-1.
9. Robertson NP, O'Riordan JI, Chataway J, et al. Clinical characteristics and offspring recurrence rates of conjugal multiple sclerosis. Lancet 1997; 349:587-90.
10. Risch N. Linkage strategies for genetically complex traits. Am J Hum Genet 1990; 46:222-53.
11. Olerup O, Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 1991; 38:1-15.
12. Marrosu MG, Muntoni F, Murru MR, et al. HLA-DQB1 genotype in Sardinian multiple sclerosis: evidence for a key role of DQB1.0201 and DQB1.0302 alleles. Neurology 1992; 42:883-6.
13. Coraddu F, Reyes-Yanez MP, Aladro Y, et al. HLA associations with multiple sclerosis in the Canary Islands. J Neuroimmunol 1998; 87:130-5.
14. Saruhan-Direskeneli G, Esin S, Baykan-Kurt B, et al. HLA-DR and -DQ associations with multiple sclerosis in Turkey. Hum Immunol 1997; 55:59-65.
15. Mycko MP. Kwinkowoski M, Tronczynska E, et al. Multiple sclerosis: increased frequency of the ICAM-1 exon 6 gene point mutation genetic type K469. Ann Neurol 1998; 44:70-5.
16. De La Concha EG, Arroyo R, Crusius JB, et al. Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis. J Neuroimmunol 1997; 80:172-8.
17. Wansen K, Pastinen T, Kuokkanen S, Wokstrom J, et al. Immune system genes in multiple sclerosis: genetic association and linkage analyses on TCR-β, IgH, IFN-gamma and IL-12ra/IL-1β loci. J of Neurol 1997; 79:29-36.
18. Vanderbroeck K, Martino G, Marrosu M, et al. Occurrence and clinical relevance of an interleukin-4 gene polymorphism in patients with multiple sclerosis. J Neuroimmunol 1997; 76:189-92.
19. He B, Xu C, Yang B, Landtblom A-M, Fredrikson S, Hillert J. Linkage and association analysis of genes encoding cytokines and myelin proteins in multiple sclerosis. J Neuroimmunol 1998; 86:13-9.
20. Bennets BH, Teutsch SM, Buhler MM, et al. The CCR5 deletion mutation fails to protect against multiple sclerosis. Hum Immunol 1997; 58:52-9.
21. He B, Yang B, Lundahl J, et al. The myelin basic protein gene in multiple sclerosis: identification of discrete alleles of a 1.3kb tetranucleotide repeat sequence. Acta Neurolog Scand 1998; 97:46-51.
22. Ligers A, He B, Fogdell-Hahn A, Olerup O, Hillert J. No linkage or association of a VNTR marker in the junction region of the immunoglobulin heavy chain genes in multiple sclerosis. Eur J Immunogenet 1997; 24:259-64.
23. Droogan AG, Kirk CW, Hawkins SA, et al. T cell receptor alpha, beta, gamma and delta chain microsatellites show no association with multiple sclerosis. Neurology 1996; 47:1049-53.
24. Tienari P, Wikstrom J, Sajantila A, Palo J, Peltonen L. Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene. Lancet 1992; 340:987-91.
25. Tienari P, Kuokkanen S, Pastinen T, et al. Golli-MBP gene in multiple sclerosis. J Neuroimmunol 1998; 81:158-67.
26. Nellemann LJ, Frederiksen J, Morling N. PCR typing of two short tandem repeat (STR) structures upstream of the human myelin basic protein (MBP) gene; genetic susceptibility in multiple sclerosis and monosymptomatic idiopathic optic neuritis in Danes. Multiple Sclerosis 1995; 1:186-9.
27. Thompson RJ, Mason CR, Douglas AJ, et al. Analysis of polymorphisms of the 2′3′-cyclic nucleotide-3′-phosphodiesterase gene in patients with multiple sclerosis. Multiple Sclerosis 1996; 2:215-21.
28. Price SE, Sharpe G, Boots A, et al. Role of myelin basic protein and proteolipid protein genes in multiple sclerosis: single strand conformation polymorphism analysis of the human sequences. Neuropathol Appl Neurobiol 1997; 23:457-67.
29. Rodriguez D, Della Gaspera B, Zalc B, et al. Identification of a Val 145 lle substitution in the human myelin oligodendrocyte glycoprotein: lack of association with multiple sclerosis. Multiple Sclerosis 1997; 3:377-82.
30. Reboul J, Mertens C, Levillayer F, et al. Cytokines in genetic susceptibility to multiple sclerosis: a candidate gene approach. J Neuroimmunol 2000; 102:107-12.
31. Sawcer S, Jones HB, Feakes R, et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nature Genet 1996; 13:464-8.
32. Chataway J, Feakes R, Coraddu F, et al. The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen. Brain 1998; 121:1869-87.
33. Ebers GC, Kukay K, Bulman D, et al. A full genome search in multiple sclerosis. Nature Genet 1996; 13:472-6.
34. Multiple Sclerosis Genetics Group. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nature Genet 1996; 13:469-71.
35. Kuokkanen S, Gschwend M, Rioux JD, et al. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am J Hum Genet 1997; 61:1379-87.
36. Xu C, Dai Y, Fredrikson, Hillert J. Association and linkage analysis of candidate chromosomal regions in multiple sclerosis: indication of disease genes in 12q23. Eur J Hum Genet 1999; 7:110-6.
37. D'Alfonso S, Nistico L, Zavattari P, et al. A linkage analysis of multiple sclerosis with candidate region markers in Sardinian and continental Italian families. Eur J Hum Genet 1999; 7:377-85.
38. Kellar Wood H, Robertson N, Govan GG, et al. Leber's hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis. Ann Neurol 1994; 36:109-12.
39. Kalman B, Lublin FD, Alder H. Mitochondrial DNA mutations in multiple sclerosis. Multiple Sclerosis 1995; 1:32-6.
40. Nishimura M, Obayashi H, Ohta M, et al. No association of the 11778 mitochondrial mutation and multiple sclerosis in Japan. Neurology 1995; 45:1333-4.
41. Harding AE, Sweeney MG, Brockington M, et al. Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain 1992; 115:989-989.
42. Riordan Eva P, Sanders MD, Govan GG, et al. The clinical features of Leber's hereditary optic neuropathy defined by the presence of pathogenic mitochondrial DNA mutation. Brain 1995; 118:319-37.
43. Coraddu F, Sawcer S, Feakes R, et al. HLA typing in the United Kingdom multiple sclerosis genome screen. Neurogenetics 1999; 2:24-33.